Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 69 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| PRDM14 | ENSG00000147596 | 0.00 | 0.00 | 0 | 0 |
| SLC26A7 | ENSG00000147606 | 0.00 | 0.00 | 0 | 0 |
| SLC39A4 | ENSG00000147804 | 0.88 | 0.00 | 3 | 0 |
| CER1 | ENSG00000147869 | 0.00 | 0.00 | 0 | 0 |
| PLIN2 | ENSG00000147872 | 0.00 | 0.00 | 0 | 0 |
| IFNA5 | ENSG00000147873 | 0.00 | 0.00 | 0 | 0 |
| IFNA16 | ENSG00000147885 | 0.00 | 0.00 | 0 | 0 |
| IFNK | ENSG00000147896 | 0.00 | 0.00 | 0 | 0 |
| SIGMAR1 | ENSG00000147955 | 0.17 | 0.00 | 1 | 0 |
| C9orf3 | ENSG00000148120 | 0.00 | 0.00 | 0 | 0 |
| OR13C4 | ENSG00000148136 | 0.00 | 0.00 | 0 | 0 |
| CRB2 | ENSG00000148204 | 0.00 | 0.00 | 0 | 0 |
| OR5C1 | ENSG00000148215 | 0.00 | 0.00 | 0 | 0 |
| PTGES | ENSG00000148344 | 0.00 | 0.22 | 0 | 1 |
| LCN2 | ENSG00000148346 | 0.00 | 0.00 | 0 | 0 |
| LCN9 | ENSG00000148386 | 0.00 | 0.00 | 0 | 0 |
| SLC39A12 | ENSG00000148482 | 0.00 | 0.00 | 0 | 0 |
| RGR | ENSG00000148604 | 0.00 | 0.00 | 0 | 0 |
| CYP17A1 | ENSG00000148795 | 0.00 | 0.00 | 0 | 0 |
| GSTO1 | ENSG00000148834 | 0.00 | 0.51 | 0 | 3 |
|
Showing page 69 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.